Corbus Pharmaceuticals Hldgs Inc (CRBP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Operating Expenses | 24,417 | 19,152 | 19,775 | 12,605 | 15,505 |
| Operating Income | -24,417 | -19,152 | -19,775 | -12,605 | -15,505 |
| Interest Expense | 0 | 0 | 0 | 0 | 381 |
| Other Income | 1,075 | 1,490 | 2,797 | 3,075 | 2,103 |
| Pre-tax Income | -23,342 | -17,662 | -16,978 | -9,530 | -13,783 |
| Net Income Continuous | -23,342 | -17,662 | -16,978 | -9,530 | -13,783 |
| Net Income | $-23,342 | $-17,662 | $-16,978 | $-9,530 | $-13,783 |
| EPS Basic Total Ops | -1.90 | -1.44 | -1.39 | -0.80 | -1.15 |
| EPS Basic Continuous Ops | -1.90 | -1.44 | -1.39 | -0.80 | -1.15 |
| EPS Diluted Total Ops | -1.90 | -1.44 | -1.39 | -0.80 | -1.15 |
| EPS Diluted Continuous Ops | -1.90 | -1.44 | -1.39 | -0.80 | -1.15 |
| EPS Diluted Before Non-Recurring Items | -1.90 | -1.44 | -1.39 | -0.78 | -1.15 |
| EBITDA(a) | $-24,417 | $-19,519 | $-19,898 | $-13,298 | $-15,910 |